Analyzing the trends and forecasting Global Liver Cancer Therapeutics Analyzing the trends and forecasting Global Liver | Page 3

 Hepatoblastoma
 Targeted Therapy
3) By End-Users
 Pediatrics
 Adults
Based on geography the market is analysed under various regions namely, North America,
Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America is the largest
market for liver cancer therapeutics followed by Europe and Asia. Also, Asia-Pacific signifies
the fastest growing region for liver cancer therapeutics market, owing to increasing aged
populations. Increasing number of liver cancer cases in the Asian countries is further fuelling
this regions market.





North America Liver Cancer Therapeutics Market
Europe Liver Cancer Therapeutics Market
Asia-Pacific Liver Cancer Therapeutics Market
Latin America Liver Cancer Therapeutics Market
Middle East and Africa Liver Cancer Therapeutics Market
Some of the key contributors in the industry include Alnylam Pharmaceuticals Inc., ImClone Systems
Inc., Onyx Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., ArQule Inc., Jennerex
Biotherapeutics Inc., Celsion Corp., Bayer Schering Pharma AG, 4SC AG, and Bristol-Myers Squibb
Company.
The Liver Cancer Therapeutics Market study offers the following deliverables:




Global, regional and country-level analysis and forecasts of the study market;
providing Insights on the geographical areas in which this industry is blooming
Segment-level analysis on basis of product type, application, colour along with
market size forecasts and y-o-y estimations to detect key areas of industry growth in
detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the
market and their impact on shifting market dynamics
Study of macro and micro environmental factors that effect the global market
presented in an extensive strategic analyses section containing PESTLE and Porter’s
Five Forces Analyses